🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Read about collaborative dialogues convened by KELIN with support from Aidsfonds International focusing on HIV prevention tools and IP challenges affected access to medicines. Mercy Pesa Okania Read prevention study findings here: kelinkenya.org/wp-content/upl… kelinkenya.org/collaborative-…

How can we turn breakthroughs in long-acting #HIV prevention & therapy into real-world impact? Despite promising advancements, urgent coordination is needed to ensure access in low- & middle-income countries where HIV is most prevalent. Read more 👉🏽bit.ly/lancet-hiv

#HIV #TB #Kenya KELIN

🚨 A research paper has been published, demonstrating how #lenacapavir could be mass-produced for $40 per year to meet increased demand. The paper was prepared with the support of the ITPC Global Make Medicines Affordable campaign. Read more: ⚡️💊👇🏿 #HIV academic.oup.com/jac/advance-ar…

There have been over a million new cases of #HIV each year.  #Lenacapavir, a long-acting antiretroviral, could change the trajectory of this global epidemic, but Gilead Sciences' patent monopoly will keep it unaffordable for many in urgent need. ⚡️🚨👇🏿 tinyurl.com/mvw59wb2

“Without a steady supply of affordable #Lenacapavir from India, ending #AIDS will remain an elusive goal. Decisions made by #Indian patent offices are a matter of life or death for people living with #HIV/AIDS worldwide.” Read more on our website: 🚨⚡️👇🏿 tinyurl.com/2dh78kw8

#Lenacapavir #HIV #PrEP #LivesNotProfit

We’re at a pivotal moment in history as we approach the United Nations #SummitoftheFuture on September 22-23. The Summit holds great promise for building a better present and safeguarding the future. However, a key challenge remains at risk of being overlooked: Health.

We need a pact for the #future with lower prices through #generic competition, omellouk , lead of the intellectual property and access to medicines program #MMA at ITPC Global

A #PactForTheFuture must embrace diversity and fight all forms of discrimination, ensuring equality across gender, race, age & disability. 🚫No health, no future! WACI Health GNP+ GlobalFundAdvocates Frontline AIDS STOPAIDS Solange Baptiste #SummitoftheFuture2024

🌍 The Pact for the Future is here, but without clear action, change remains distant. With only 15% of #SDGs on track, we urgently need a shift in global cooperation to achieve real progress. 🧵Enter Global Public Investment #SummitoftheFuture Solange Baptiste Global Public Investment Network

📌Pact for the Future & Beyond: Towards FfD4 We call for: 1️⃣ Focus on global public finance 2️⃣ Reform financial institutions 3️⃣ Build inclusive global funds 4️⃣ Expand grants so low-income countries aren’t burdened Solange Baptiste Global Public Investment Network #SummitOfTheFuture

#accesstomedicines #kenya #intellectualproperty

ITPC Global KELIN Make Meds Affordable UNAIDS Kenya UNAIDS Global CEHURD Uganda ENDA SANTE Mercy Pesa Okania Namulanda Today, civil society reps from Kenya, Morocco, Senegal, Malawi, Tunisia & Uganda gather for a training on intellectual property and its impact on access to medicines. The training is organised by ITPC MENA in collaboration with KELIN with support from ITPC Global

Every Kenyan, including those living with HIV, deserves consistent, accessible, and high-quality healthcare. The Constitution guarantees the right to the highest attainable standard of health for all. #EndARVStockoutsKe. AYARHEP-KENYA AHF Kenya Patricia Asero Stop TB Partnership

🌍✨ Health is not just a priority; it’s fundamental for our future. itpcglobal.org/2024/09/25/hea… #commit2health WACI Health Frontline AIDS GlobalFundAdvocates GNP+ STOPAIDS Solange Baptiste

Unless you are in Brazil, Mexico, plus. 🚨 See Health GAP statement.

#Lenacapavir has the potential to transform #HIV prevention, but only if it is made truly accessible to everyone who needs it, without restrictions and exclusions. Gilead Sciences VL will prevent millions of people from accessing #LEN. Read more: ⚡️💉👇🏿 tinyurl.com/52px2tn5

#Lenacapavir has the potential to transform HIV prevention  -  but only if it is made truly accessible to everyone who needs it, without restrictions and exclusions. Read ITPC Global’s reaction to Gilead’s voluntary licence here makemedicinesaffordable.org/why-the-world-… Make Meds Affordable

Gilead’s announcement of their voluntary license for lenacapavir (a groundbreaking, long-acting HIV prevention method) highlights why we cannot rely on pharmaceutical companies to deliver genuine global access strategies to health. Make Meds Affordable itpcglobal.org/2024/10/07/why…